Imaging and nanomedicine in inflammatory atherosclerosis - Test2 - elhamkhani - TriplyDB

Imaging and nanomedicine in inflammatory atherosclerosis

Imaging and nanomedicine in inflammatory atherosclerosis

http://www.wikidata.org/entity/Q27002916

about

Cardiovascular imaging: what have we learned from animal models?Nanoparticles for Cardiovascular Imaging and Therapeutic Delivery, Part 2: Radiolabeled Probes Imaging of small animal peripheral artery disease models: recent advancements and translational potential Intravascular optical imaging of high-risk plaques in vivo by targeting macrophage mannose receptors.Atherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging."Eat me" imaging and therapy Imaging systemic inflammatory networks in ischemic heart disease Atherosclerosis and Nanotechnology: Diagnostic and Therapeutic Applications.Imaging inflammation and neovascularization in atherosclerosis: clinical and translational molecular and structural imaging targets Polymeric Nanostructures for Imaging and Therapy PET and MR imaging of neuroinflammation in hepatic encephalopathy.Targeted Near-Infrared Fluorescence Imaging of Atherosclerosis: Clinical and Intracoronary Evaluation of Indocyanine Green.Nanomedical engineering: shaping future nanomedicines.Ischemic stroke activates hematopoietic bone marrow stem cells Robust passive and active efflux of cellular cholesterol to a designer functional mimic of high density lipoprotein A new approach to reduce toxicities and to improve bioavailabilities of platinum-containing anti-cancer nanodrugs.SPECT/CT Imaging of High-Risk Atherosclerotic Plaques using Integrin-Binding RGD Dimer Peptides.Pharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapy.Unmasking Silent Endothelial Activation in the Cardiovascular System Using Molecular Magnetic Resonance Imaging Imaging Macrophage and Hematopoietic Progenitor Proliferation in Atherosclerosis Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration.Silica-coated Gd(DOTA)-loaded protein nanoparticles enable magnetic resonance imaging of macrophages.Detection of atherosclerotic lesions and intimal macrophages using CD36-targeted nanovesicles.Monocyte and macrophage contributions to cardiac remodeling.Engineering nanomaterials to address cell-mediated inflammation in atherosclerosis.Hybrid nanoparticles improve targeting to inflammatory macrophages through phagocytic signals.Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy.Mechanism of hard-nanomaterial clearance by the liver.Targeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis.Use of Nanoparticles As Contrast Agents for the Functional and Molecular Imaging of Abdominal Aortic Aneurysm The evolution of our understanding of macrophages and translation of findings toward the clinic.Applying nanomedicine in maladaptive inflammation and angiogenesis.Bolstering cholesteryl ester hydrolysis in liver: A hepatocyte-targeting gene delivery strategy for potential alleviation of atherosclerosis.Everolimus-eluting stents stabilize plaque inflammation in vivo: assessment by intravascular fluorescence molecular imaging.Deformable Discoidal Polymeric Nanoconstructs for the Precise Delivery of Therapeutic and Imaging Agents.Sequential Acute Coronary Syndrome 4 Days Apart: A Missed Opportunity?Cancer imaging using surface-enhanced resonance Raman scattering nanoparticles.Polymer Capsules for Plaque-Targeted In Vivo Delivery.Vessel wall characterization using quantitative MRI: what's in a number?Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr-/- Mice.

P2860

Q26779676-32975A47-1613-4441-A4AC-E11C2F722FE4 Q26796221-2F3612D2-96F5-4A80-9EE5-06391CD4AB1C Q27009178-FC57C26B-90B0-439A-B98E-B4211D061B3B Q27334277-726B38BA-F9BA-41E1-98C0-AE60D634AD0E Q27334823-55FC6112-8FF9-4E25-84EA-ED8CFD7B193E Q28394148-891CA309-DFAB-48CE-AE10-DC1AF8A4C2BB Q30316648-9F7982E0-FE3B-4205-BA30-343F01AC18EE Q30364399-4C717385-B4D9-4DF0-BE47-3E49647670C4 Q30370897-5B09D39D-2855-4B25-BCB9-D087F36851C1 Q30372383-5200FB11-E8BA-4C9C-99DB-74070B87ACCA Q30878855-214A75C8-39DB-4B25-8A1B-F056A36C7086 Q34537947-0FEB2F28-781A-4346-91E2-F23D1F8392C2 Q35019550-BF8537A3-2631-4AA8-90A9-2466C2C61F2C Q35033609-37C41715-C716-490A-BA6F-8FF9E72990E8 Q35536400-196C3C7E-1F9F-4BB6-9E49-4AF28E011AC0 Q35679127-E2474CEB-7F86-4353-A506-03C0A8325B61 Q35796600-06DBA55F-CA15-4B01-A56F-F4F3695FEE17 Q35831733-60608A02-0423-4F96-84C5-6254386285F6 Q36056187-44526FE9-1D82-44DE-A310-6BA561E98F1F Q36202794-DF6AC464-3396-4125-8A8A-FEAAF4FF4607 Q36223678-BCD3E91F-50F0-4AF5-85BE-020C617E8F06 Q36361995-B7ABB324-392E-4D62-89E3-79A84F07C113 Q36396054-F4274C31-8458-4EF8-8658-C6A83FC12FF3 Q36840151-55392597-E295-4C97-8AE4-86D2A0F9CFB4 Q36848196-7F7B7AF2-F1E9-4718-B020-1B65B6A3F79A Q36920492-75261373-F002-4934-8448-E0D91B73E3D7 Q37024507-25D6B7A2-3197-4781-9488-D0B04926DBCD Q37462904-C90254F6-C764-4810-92AF-46BAB5B1E958 Q37544674-C8C89DD3-8716-475F-BDF9-41D213E075D2 Q37716747-58F72423-F9AC-460C-B157-4AAC17D8E0CD Q38272795-770C74E5-FF7C-4FB5-87DB-6D6863051875 Q38557650-AFDC8955-473E-4FE2-A4EA-95A1D8370B92 Q38871582-D840B86E-755A-412E-A1A1-251FAF24D872 Q39048973-AF149F9E-7B6E-4BA2-AADF-4404BB4EC52D Q39199893-1DF338B7-E98E-42B3-9FF6-3B60069FE832 Q47107827-0B48DD8C-6695-420A-B613-98ACEB2DFF5F Q47162415-BA67CBC2-ABF3-4D25-9101-EA2969E14802 Q47567962-386F63C0-B268-4204-91AB-D30D42A0B1C3 Q47794497-F5B33978-3B04-455A-9C58-F13A911E73BA Q47898903-66EAC945-B91F-4BEE-9911-D0B0F22D83FC

P2860

Imaging and nanomedicine in inflammatory atherosclerosis

http://www.wikidata.org/entity/Q27002916

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Imaging and nanomedicine in inflammatory atherosclerosis

@ast

Imaging and nanomedicine in inflammatory atherosclerosis

@en

Imaging and nanomedicine in inflammatory atherosclerosis

@nl

type

label

Imaging and nanomedicine in inflammatory atherosclerosis

@ast

Imaging and nanomedicine in inflammatory atherosclerosis

@en

Imaging and nanomedicine in inflammatory atherosclerosis

@nl

prefLabel

Imaging and nanomedicine in inflammatory atherosclerosis

@ast

Imaging and nanomedicine in inflammatory atherosclerosis

@en

Imaging and nanomedicine in inflammatory atherosclerosis

@nl

P1433

Q27002916-6EEAEA0B-B8ED-4138-93B4-C6FE1C337197

P1476

Q27002916-FB7F8DC4-B924-46E4-A4A5-CFD6A6D40E94

P2093

Q27002916-6F9C537B-F09C-4EF7-A547-62A9276C1C02

Q27002916-78D2647A-1C72-4D7D-B564-74375B905E58

Q27002916-A254D9D0-8E97-4E3F-9100-F140433B6BDA

P2860

Q27002916-020BDB99-7013-46E7-B49B-855E4D68A517

Q27002916-06D8A204-F532-47DD-B5FD-41423F5A0CE4

Q27002916-07955A04-BFBB-4D15-B242-2A43DB00EEA5

Q27002916-0C2F9FC0-9D8C-48D7-98D0-99E593E58595

Q27002916-0C52F2E3-160A-4BC5-BA1A-3A9FFD330A29

Q27002916-0F505243-6789-4C87-A5EC-23D1DAB69FD6

Q27002916-120B543E-4052-4F97-A139-E09EA1468908

Q27002916-16EF9816-7002-4E05-98D1-A8BCAD7CE015

Q27002916-18195FDA-B5DD-4A42-A658-809BFD8B6CB1

Q27002916-184EBAFE-EC1A-4233-92D6-CF8B3444FD95

P304

Q27002916-761F47AB-9C90-4C4A-850F-A8EE8EDF0FCB

P31

Q27002916-07876119-991B-47F4-A225-4E7602289DA6

P3181

Q27002916-5FD5ADC7-A567-41D1-A8DF-D8CC9023F3B3

P356

Q27002916-4C517347-1E83-4FD1-AEBA-F55319B051CA

P407

Q27002916-88A81625-1829-46EF-B584-83D7D1C30D23

P433

Q27002916-917974E4-A738-44D2-B558-D48622BB1F98

P478

Q27002916-D0FE48C3-912D-426C-BAD9-CDFB014325EB

P50

Q27002916-B01E4379-61AA-4615-ABFF-87092F92F63D

P577

Q27002916-F386043A-A2B0-4F59-B10C-525758ADCF62

P5875

Q27002916-F2A8449F-2C4E-47E5-AA82-D849D7379C0D

P698

Q27002916-BA09CF8E-ADFC-4413-9233-A332DE3EF146

P921

Q27002916-3DDB74E4-58B4-468C-BA37-D99B587911B2

Q27002916-936DC0DD-E8CC-48E2-95B1-DB70F2D988CA

P932

Q27002916-134FDD07-B739-4026-97AD-501C4EAA6E0E

P3181

P356

SCITRANSLMED.3005101

P1433

Science Translational Medicine

P1476

Imaging and nanomedicine in inflammatory atherosclerosis

@en

P2093

Farouc A Jaffer

http://www.w3.org/2001/XMLSchema#string

Matthias Nahrendorf

http://www.w3.org/2001/XMLSchema#string

Zahi A Fayad

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular Imaging

Identification of splenic reservoir monocytes and their deployment to inflammatory sites

Anti-inflammatory therapy in chronic disease: challenges and opportunities

IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses

Therapeutic inflammatory monocyte modulation using immune-modifying microparticles

Inflammation in atherosclerosis

Macrophages in the pathogenesis of atherosclerosis

Effects of torcetrapib in patients at high risk for coronary events

Progress and challenges in translating the biology of atherosclerosis

Dynamic T cell-APC interactions sustain chronic inflammation in atherosclerosis

P304

239sr1

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

664071

http://www.w3.org/2001/XMLSchema#string

P356

10.1126/SCITRANSLMED.3005101

http://www.w3.org/2001/XMLSchema#string

P407

P433

239

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Willem J.M. Mulder

P577

2014-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262884536

http://www.w3.org/2001/XMLSchema#string

P698

24898749

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

4110972

http://www.w3.org/2001/XMLSchema#string